Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 29;60(6):905.
doi: 10.3390/medicina60060905.

Epigenetics in Glaucoma

Affiliations
Review

Epigenetics in Glaucoma

Fabiana D'Esposito et al. Medicina (Kaunas). .

Abstract

Primary open angle glaucoma (POAG) is defined as a "genetically complex trait", where modifying factors act on a genetic predisposing background. For the majority of glaucomatous conditions, DNA variants are not sufficient to explain pathogenesis. Some genes are clearly underlying the more "Mendelian" forms, while a growing number of related polymorphisms in other genes have been identified in recent years. Environmental, dietary, or biological factors are known to influence the development of the condition, but interactions between these factors and the genetic background are poorly understood. Several studies conducted in recent years have led to evidence that epigenetics, that is, changes in the pattern of gene expression without any changes in the DNA sequence, appear to be the missing link. Different epigenetic mechanisms have been proven to lead to glaucomatous changes in the eye, principally DNA methylation, post-translational histone modification, and RNA-associated gene regulation by non-coding RNAs. The aim of this work is to define the principal epigenetic actors in glaucoma pathogenesis. The identification of such mechanisms could potentially lead to new perspectives on therapeutic strategies.

Keywords: DNA methylation; epigenetics; glaucomatous neurodegeneration; histone modifications; non-coding RNAs; open angle glaucoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Epigenetic modifications in glaucoma.
Figure 2
Figure 2
Interaction of factors in glaucoma pathogenesis.

References

    1. Harasymowycz P., Birt C., Gooi P., Heckler L., Hutnik C., Jinapriya D., Shuba L., Yan D., Day R. Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. J. Ophthalmol. 2016;2016:6509809. doi: 10.1155/2016/6509809. - DOI - PMC - PubMed
    1. Weinreb R.N., Leung C.K., Crowston J.G., Medeiros F.A., Friedman D.S., Wiggs J.L., Martin K.R. Primary open-angle glaucoma. Nat. Rev. Dis. Primers. 2016;2:16067. doi: 10.1038/nrdp.2016.67. - DOI - PubMed
    1. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed
    1. Gauthier A.C., Liu J. Epigenetics and Signalling Pathways in Glaucoma. Biomed. Res. Int. 2017;2017:5712341. doi: 10.1155/2017/5712341. - DOI - PMC - PubMed
    1. Allison K., Patel D., Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus. 2020;12:e11686. doi: 10.7759/cureus.11686. - DOI - PMC - PubMed

LinkOut - more resources